Tag: car
-
New data on risk vs benefit for potent CAR-T cancer drugs
A promising but risky new group of customized cancer drugs will be in focus this weekend at the annual meeting of the American Society of Hematology (ASH), where clinical trial results will help clarify their potential for doctors and investors. Experimental chimeric antigen receptor T-cells, or CAR-Ts, are made by genetically altering a patients’ own…
-
Kite immunotherapy drug helps blood cancer patients in study
(Reuters) – Kite Pharma Inc on Monday said its experimental CAR T-cell therapy, which helps the immune system fight cancer, was highly effective in treating aggressive non-Hodgkin lymphoma, although two deaths were related to the drug, according to interim data from a midstage trial. Shares of Kite, which had been halted before the release of…